Parkinson’s disease is the second most common neurological condition worldwide, yet it remains one of the least understood.

Supported by PHRN’s data linkage infrastructure, Dr Peter Micalos and colleagues uncovered significant differences in Parkinson’s medication prescribing across New South Wales.

“Parkinson’s disease is a complex, progressive condition, and managing it effectively requires access to specialist knowledge and ongoing review of treatment. When that access is limited, it can directly affect patient outcomes,” Dr Micalos said.

Read the Impact Story